Includes 22,500 shares of unvested restricted stock that will vest within 60 days of April 16, 2019, on May 16, 2019, subject to continued service on the vesting date.
(5)
Excludes 5,115 unvested RSUs that vest in full on April 3, 2020, 8,926 unvested RSUs that vest 50% on each of March 30, 2020 and 2021, and 9,287 unvested RSUs that vest 33% on each of March 30, 2020, 2021 and 2022, subject to continued service on the vesting date.
(6)
Includes 46,436 shares held directly by Mr. Ein and 3,456,416 shares held by Capitol Acquisition Management 2 LLC, of which Leland Investments Inc., an entity controlled by Mr. Ein, is the sole member. As a result, Mr. Ein has voting and dispositive control over such shares. Includes 352,500 warrants to purchase shares of common stock and 3,652,175 warrants to purchase shares of common stock held by Capitol Acquisition Management 2 LLC. Excludes 8,225 shares of restricted stock held by Mr. Ein that vests in full on August 8, 2019 and 4,793 shares of restricted stock held by Mr. Ein that vest 50% August 8, 2019 and 2020, subject to continued service on the vesting date.
(7)
Includes 1,334,891 warrants to purchase shares of common stock and excludes 8,225 shares of restricted stock that vests in full on August 8, 2019, and 4,793 shares of restricted stock that vests 50% August 8, 2019 and 2020, subject to continued service on the vesting date.
(8)
Amount excludes 8,225 shares of restricted stock that vests in full on August 8, 2019 and 4,793 shares of restricted stock that vests 50% August 8, 2019 and 2020, subject to continued service on the vesting date.
(9)
Amount excludes 5,522 shares of restricted stock that vests in full on August 8, 2019 and 3,616 shares of restricted stock that vests 50% on August 8, 2019 and 2020, subject to continued service on the vesting date.
(10)
Amount excludes 8,225 shares of restricted stock that vests in full on August 8, 2019 and 4,793 shares of restricted stock that vests 50% on August 8, 2019 and 2020, subject to continued service on the vesting date.
(11)
Information from Schedule 13G/A filed on February 12, 2019 by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP (“WMC”). Each of the entities reported shared voting power over 2,925,240 shares and shared dispositive power over 3,380,273 shares other than WMC who reported shared voting power over 2,925,240 shares and shared dispositive power over 3,111,085 shares. The address of the reporting entities is c/o Wellington Management Company LLP, 280 Congress Street, Boston, MA 02210.
(12)
Information from Schedule 13G/A filed on February 14, 2019 by T. Rowe Price Associates, Inc. and T. Rowe Price New Horizons Funds, Inc. T. Rowe Price Associates, Inc. reported sole voting power over 724,069 shares and sole dispositive power over 4,236,677 shares. T. Rowe Price New Horizons Funds, Inc. reported sole voting power over 3,512,60 shares. The address of the reporting entities is 100 E. Pratt Street, Baltimore, MD 21202.
(13)
Information from Schedule 13D/A filed on March 28, 2019 by ValueAct Spring Master Fund, L.P., (b) VA Partners I, LLC, (c) ValueAct Capital Management, L.P., (d) ValueAct Capital Management, LLC, (e) ValueAct Holdings, L.P. (f) ValueAct Holdings II, L.P. and (g) ValueAct Holdings GP, LLC reported shared voting and dispositive power over all of the shares. The address of the reporting entities is One Letterman Drive, Building D, Fourth Floor, San Francisco, CA 94129.
(14)
Information from Schedule 13G filed on April 15, 2019 by Highbridge Capital Management, LLC and Highbridge MSF International Ltd. Reporting shared voting and dispositive power over 2,500,000 shares of common stock issuable upon the exercise of outstanding warrants. Highbridge MSF International Ltd. may be deemed to beneficially own 2,500,000 shares of common stock issuable upon exercise of warrants and Highbridge Capital Management, LLC, as the trading manager of Highbridge MSF International Ltd., may be deemed to be the beneficial owner of the 2,500,000 shares of common stock issuable upon exercise of warrants held by Highbridge MSF International Ltd. The address of the reporting entities is 40 West 57th Street, 32nd Floor, New York, New York 10019.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires our directors, executive officers and stockholders holding more than 10% of our outstanding common stock to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in beneficial ownership of our common stock. Section 16(a) filers are required by Securities and Exchange Commission regulations to furnish us with copies of all Section 16(a) reports they file. Based on a review of the ownership reports filed with Securities and Exchange Commission during 2018, we believe that all Section 16(a) filing requirements were met on a timely basis other than an inadvertent late Form 4 filed by each of Philip Auerbach, Craig Felenstein, Trey Byus and Sven-Olof Lindblad with respect to the grant of an equity award and the disposition of shares for taxes upon vesting of an equity award and two late Form 4s filed by John Fahey reporting the grant of shares in lieu of a cash retainer.